Herpes zoster: a potential risk associated with fingolimod treatment

Int J Dermatol. 2015 Sep;54(9):e373-5. doi: 10.1111/ijd.12878. Epub 2015 Jul 14.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acyclovir / analogs & derivatives
  • Acyclovir / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Fingolimod Hydrochloride / adverse effects*
  • Fingolimod Hydrochloride / therapeutic use
  • Follow-Up Studies
  • Herpes Zoster / chemically induced*
  • Herpes Zoster / drug therapy
  • Herpes Zoster / pathology
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Middle Aged
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / drug therapy*
  • Recurrence
  • Risk Assessment
  • Treatment Outcome
  • Valacyclovir
  • Valine / analogs & derivatives
  • Valine / therapeutic use

Substances

  • Immunosuppressive Agents
  • Fingolimod Hydrochloride
  • Valine
  • Valacyclovir
  • Acyclovir